Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
Although CT is a relatively recent technology, there have been great improvements in the equipment. The early, slow "Step and Scan" machines required long image acquisition times, resulting in a ...
PARIS, France—Using a virtual coronary road-map overlay during angiography for complex PCI can significantly reduce the amount of iodinated contrast and the number of cineangiography runs, potentially ...
Positive oral CT contrast improves detection of malignant deposits in intraabdominal nonsolid organs
Choice of oral contrast agent and adequacy of preparation impact detection of intraabdominal nonsolid malignant deposits on CT, although NPV remains suboptimal “CT has suboptimal NPV for malignant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback